SEC Filing | CONMED

View:

SEC FORM 4 SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Farkas Charles

(Last)

(First)

(Middle)

C/O CONMED CORPORATION

11311 CONCEPT BOULEVARD

(Street)

LARGO

33773

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
CONMED Corp [ CNMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
05/31/2024

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Rule 10b5-1(c) Transaction Indication

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/31/2024		M		302	A	$0	19,880	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Rsus (restricted Stock Units)	$0	05/31/2024		M			302	05/31/2024⁽¹⁾	06/01/2033	Common Stock	302	$0	0	D
Options To Purchase Common Stock	$77.18	06/03/2024		A		5,503		06/03/2025⁽²⁾	06/03/2034	Common Stock	5,503	$0	5,503	D
Rsus (restricted Stock Units)	$0	06/03/2024		A		479		06/03/2025⁽¹⁾	06/03/2034	Common Stock	479	$0	479	D

Explanation of Responses:

1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period.

2. The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period.

	/s/ Thomas Fistek for Charles Farkas by Power of Attorney	06/04/2024
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

CONMED CORPORA1'ION
LIMITED POWER OF ATTORNEY FOR SECTION 16 AND RULE 144 FILINGS AND LOCK? UP
AGREEMENTS

Know all by these prescntsi that the undersigned hereby constitutes and
appoints each of the following attorneys ofCONMED Corporation (the "Company"):
Heather L. Cohen, Esq., the EVP and Chief Human Resources and Legal Officer;
Lindsey F. Brewer, Esq., Associate General Counsel; Thomas Fistek, Esq., Chief
IP Counsel, as the undersigned's true and lawful attorney-in-fact to: l.
execute for and on behalf of the undersigned, in the undersigned's capacity as
an officer or director or both of the Company, Forms 3, 4 and 5 (and any
amendments thereto) in accordance with Se_ction 16(a) of the Securities
Exchange Act of1934, as amended and the tules and regulations promulgated
thereunder (the "Exchange Act"),, and any Fann 144 under the Securities Act of
1933, as amended, as well as any Lock-Up Agreements; 2.	do and perform any and
all acts for and on behalf of the undersigned which may be necessary or
desirable to complete and execute any such Fom1 3, 4, 5, Form 144 Notice or
Lock-Up Agreements, complete and execute any amendments thereto, and timely
file such form, with all amendments, supplements and exhibits thereto, ,vith
the Securities and Exchange Commission and any securities exchange or similar
authority: 3.	seek or obtain, as the undersigned's representative and on
the-undersigned's behalf: information on transactions in the Company's
securities from any third party, including but not limited to brokers, employee
benefit plan administrators and trustees, and the undersigned hereby authorizes
any such person to rckase any such information to each of the undersigned's
attorneys-in-fact appointed by this Limited Power of Attorney and approves and
ratifies any such release of information; and 4.	take any other action in
connection with the foregoing which, in the opinion of such attorney-in-fact,
may be of benefit to, in the best interest of, or legally required by or for,
the undersigned, it being understood that the documents executed by such
attorney-in-fact on behalf of the undersigned pursuant to this Limited Power of
Attorney shall be in such form and shall contain such information and
disclosure as such attorney-in-fact may approve in such attorney-in-fact's
discretion. The undersigned hereby grants to each such attorney-inwfact, acting
individually, full power and authority to do and perform any and every act and
thing whatsoever required, necessary or proper to be done in the exercise of
any oJ the rights and powers herein granted, as fully to all intents and
purposes as the undersigned might or could do irpcrsonally present, with full
power of substitution or revocation, hereby ratifying and confirming all that
such attorney-in-fact, or such attorney-in-fact's substitute or substitutes,
shall lawfully do or cause to be done by virtue of this Limited Power of
Attorney and the rights and powers herein granted. The undersigned acknowledges
that the foregoing attorneys-in-fact, in serving in such capacity at the
request qnd on the behalf oftbc undersigned, are not assuming, nor is the
Company assuming, any of the undersigned?s responsibilities to comply with, or
any liability for the failure to comply with, any provision of Section 16 of
the Exchange Act. This Limited Power of Attorney shall remairi in full force
and effect until the undersigned is no longer required to file Forms 3, 4, 5
and 144 and Lock-Up Agreements with respect to the undersigned's holdings of
and transactions in securities issuedby the Company, unless earlier revoked by
the undersigned in a signed writing delivered to each of the foregoing
attorneys-in-fact. IN WITNESS WHEREOF, the undersigned has executed this
Limited Power of Attorney as of this 27 day of September 2023. Charles M.
Farkas Signed and acknowledged: Charles M. Farkas Printed Name ACKNOWLEDGEMENT
STATE OF MA COUNTY OF Barnstable On September 27, 2023 , before me, the
undersigned , personally appeared Chuck Farkas, personally known to me or
proved to me on the basis of satisfactory evidenceto be the individual whose
name is subscribed to the within instrument and acknowledged to me that he/she
executed the same in his/her capacity, and that by his/ her signature on the
instrument, the individual, or the person upon behalf of which the individual
acted, executed the instrument. Paul E. Xavier Notary Public: Commonweath of
Massachusetts